You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 6,638,511


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,638,511
Title: Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
Abstract:The invention relates to nucleic acids which contain particularly a nucleotide sequence extending from the extremity constituted by the nucleotide at position (1) to the extremity constituted by the nucleotide at position (1211) represented on the figure, to the polypeptides coded by the nucleic acids. The polypeptides of the invention can be used for the diagnosis of tuberculosis, and can also be part of the active principle in the preparation of a vaccine against tuberculosis.
Inventor(s): Content; Jean (Rhode St-Genese, BE), De Wit; Lucas (Puurs, BE), De Bruyn; Jacqueline (Beersel, BE)
Assignee: N.V. Innogenetics S.A. (Ghent, BE)
Application Number:09/295,820
Patent Claims:1. An isolated polypeptide consisting of a sequence: extending from the amino acid at position 1 to the amino acid at position 46 in SEQ ID NO 3; extending from the amino acid at position 26 to the amino acid at position 46 in SEQ ID NO 3; extending from the amino acid at position 1 to the amino acid at position 340 in SEQ ID NO 3; extending from the amino acid at position 126 to the amino acid at position 340 in SEQ ID NO 3; SEQ ID NO 5; SEQ ID NO 6; SEQ ID NO 7; SEQ ID NO 16; SEQ ID NO 17; SEQ ID NO 18; SEQ ID NO 19; SEQ ID NO 20; SEQ ID NO 21; SEQ ID NO 22; or

a combination of these sequences.

2. An immunogenic composition comprising an isolated polypeptide, wherein the polypeptide consists of a sequence; extending from the amino acid at position 1 to the amino acid at position 46 in SEQ ID NO 3; extending from the amino acid at position 26 to the amino acid at position 46 in SEQ ID NO 3; extending from the amino acid at position 1 to the amino acid at position 340 in SEQ ID NO 3; extending from the amino acid at position 126 to the amino acid at position 340 in SEQ ID NO 3; SEQ ID NO 5; SEQ ID NO 6; SEQ ID NO 7; SEQ ID NO 16; SEQ ID NO 17; SEQ ID NO 18; SEQ ID NO 19; SEQ ID NO 20; SEQ ID NO 21; SEQ ID NO 22; or

a combination of these sequences.

3. The immunogenic composition of claim 2, further comprising a pharmaceutically acceptable vehicle.

4. The immunogenic composition of claim 2, wherein the polypeptide further comprises a cysteine residue added at an amino or carboxyl terminal end of the polypeptide.

5. The immunogenic composition of claim 2, wherein the polypeptide further comprises a tyrosine residue added at an amino or carboxyl terminal end of the polypeptide.

6. The immunogenic composition of claim 2, further comprising a heterologous polypeptide sequence comprising 1 to 1,000 amino acids.

7. The immunogenic composition of claim 6, wherein the heterologous polypeptide is .beta.-galactosidase.

8. An isolated polypeptide of claim 1, further comprising a heterologous polypeptide sequence comprising 1 to 1,000 amino acids.

9. An isolated polypeptide of claim 8, wherein the heterologous polypeptide is .beta.-galactosidase.

10. A polypeptide of claim 1, wherein the polypeptide is produced by a transformed, isolated host cell.

11. A polypeptide of claim 10, wherein the transformed, isolated host cell comprises a prokaryote or an eukaryotic organism.

12. A polypeptide of claim 11, wherein the transformed, isolated host cell comprises an E. coli or a Mycobacterium bovis BCG vaccine strain.

13. An isolated polypeptide consisting of a sequence: encoded by a nucleotide sequence extending from the nucleotide at position (150) to the nucleotide at position (287) in SEQ ID NO: 2; encoded by a nucleotide sequence extending from the nucleotide at position (224) to the nucleotide at position (287) in SEQ ID NO: 2; encoded by a nucleotide sequence extending from the nucleotide at position (537) to the nucleotide at position (560) in SEQ ID NO: 2; encoded by a nucleotide sequence extending from the nucleotide at position (858) to the nucleotide at position (887) in SEQ ID NO: 2; encoded by a nucleotide sequence extending from the nucleotide at position (972) to the nucleotide at position (1037) in SEQ ID NO: 2; or encoded by a nucleotide sequence extending from the nucleotide at position (1140) to the nucleotide at position (1169) in SEQ ID NO: 2.

14. A kit for conducting a diagnostic assay for tuberculosis, the kit comprising: an isolated polypeptide according to claim 1; a first reagent for making a medium appropriate for an immunological reaction; and a second reagent for detecting an antigen/antibody complex produced by an immunological reaction.

15. The kit of claim 14, wherein the second reagent comprises a labeled reagent.

16. The kit of claim 14, wherein the second reagent is recognized by a labeled reagent.

17. A kit for the diagnosis of prior exposure of a subject to M. tuberculosis, the kit comprising a preparation of a polypeptide of claim 1, said preparation inducing in vivo, after being intradermally injected to a subject, a delayed type hypersensitivity reaction at the site of injection, when the subject has had prior exposure to M. tuberculosis.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.